Abstract
In 2008, the U.S. market for interventional cardiology was valued at $US 4.6
billion. This value represents drug-eluting stents, PTCA balloons, coronary
closure devices, bare-metal stents, embolic protection devices, interventional
guidewires, diagnostic catheters, intravascular ultrasound (IVUS) catheters,
and interventional catheters. Over the forecast period, the market is
predicted to decrease in value due to limited sales of drug-eluting stents.
|